Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DPC 817

Known as: DPC-817, DPC817 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

dexelvucitabine
elvucitabine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Emerging anti-HIV drugs.
There are now exactly 20 anti-HIV drugs licenced (approved) for clinical use, and > 30 anti-HIV compounds under (pre)clinical… Expand
Review
2005
Review
2005
Emerging anti-HIV drugs
  • E. De Clercq
  • Expert opinion on emerging drugs
  • 2005
    • Corpus ID: 36139356
There are now exactly 20 anti-HIV drugs licenced (approved) for clinical use, and > 30 anti-HIV compounds under (pre)clinical… Expand
2003
2003
HIV-1 Resistance Profile of the Novel Nucleoside Reverse Transcriptase Inhibitor β-D-2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine (Reverset™)
Nucleoside reverse transcriptase inhibitors (NRTIs) represent the cornerstone of highly active antiretroviral therapy when… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Highly Cited
2002
Highly Cited
2002
Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography/tandem mass spectrometry.
  • G. Shi, J. Wu, +5 authors S. Unger
  • Rapid communications in mass spectrometry : RCM
  • 2002
    • Corpus ID: 28010193
A novel analytical method has been developed for direct quantification of intracellular nucleoside triphosphates (NTPs). Lysates… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE